Articles tagged with Congenital Heart Disease
Researchers are working on a four-year project to develop a personalized model that uses detailed blood flow information to detect obstructions in the aorta. The project aims to improve prenatal testing so that doctors can spot problems in the aorta before a baby is born and recommend treatments.
A $3 million gift from Randy Kendrick establishes the Kelly Tarantello Chair in Pediatric Cardiac Surgery at USC, supporting research into genetically engineered pig hearts as a potential bridge to heart transplant. The gift aims to save the lives and improve the health of infants with severe congenital heart disease.
University of Houston researcher Mingfu Wu has received a $3.1 million NIH grant to investigate left ventricular noncompaction, a serious heart condition that can lead to heart failure and abnormal heart rhythms. The study aims to uncover a common mechanism behind different genetic causes of LVNC and potentially identify new targets fo...
Dr. Sebastian Spethmann joins JMIR Cardio as Editor-in-Chief, bringing expertise in heart failure, cardiomyopathies, and digital health. He aims to integrate digital advancements into routine clinical care, enhancing cardiovascular health systems and patient outcomes.
A new study identified functional noncoding variants in the TBX1 enhancer that contribute to tetralogy of Fallot. These variants reduce TBX1 expression, disrupt outflow tract vessel formation, and lead to reduced angiogenesis, vessel regression, and abnormal tight junction morphology.
A new ACC Scientific Statement highlights the importance of considering cognitive impairment and frailty in cardiovascular care for older adults. The statement outlines practical strategies for prevention, screening, assessment, and management, aiming to improve outcomes such as independence, mobility, and caregiver burden.
A team of researchers from the University of Copenhagen has discovered a crucial communication system on cell surfaces that plays a significant role in heart development. Alterations in three key proteins can disrupt this system, leading to congenital heart defects.
Benoit Bruneau, director of the Gladstone Institute of Cardiovascular Disease, has been named an American Heart Association Distinguished Scientist for 2026. His work on heart development and gene regulation has advanced our understanding of cardiovascular disease and stroke.
A comprehensive review reveals a crucial role of CHD proteins in regulating gene activity during heart development. The study identifies specific members of the protein family linked to different stages of cardiac development, providing a unifying framework for understanding congenital heart defects.
Researchers found that even losing one copy of the TBX5 gene can drastically derail heart development due to DNA misfolding. The study reveals a new origin for genetic disease, suggesting that small drops in protein levels can scramble the 3D structure of DNA.
A study published in The Journal of Pediatrics found that nearly half of infants with severe heart defects were born in hospitals without cardiac surgery. Transferring these babies to a cardiac surgical center sooner was associated with shorter hospital stays compared to those transferred later.
A new study found that children of mothers with congenital heart disease face a higher risk of developmental vulnerability, including physical health and emotional maturity issues. The study, published in PLOS Medicine, analyzed over 250,000 Canadian children born to mothers with heart defects.
A simple, seven-second X-ray scan can accurately detect the severity of pulmonary valve regurgitation in patients with repaired Tetralogy of Fallot. The test uses dynamic chest radiography and requires minimal radiation, offering a more accessible diagnostic option for those who cannot undergo traditional methods.
Researchers mapped CHD variant landscape in Asian population, identifying 11 overlapping candidate genes and 25 novel genes associated with abnormal cardiovascular phenotypes. The study highlights the importance of genetic testing and counseling for birth defects in Chinese populations.
Patients with congenital heart defects are more likely to experience a first acute heart attack at an earlier age, averaging 58 years old. Despite this, there is no difference in mortality rates or risk of further heart attacks between the group with congenital heart defects and those without.
Researchers at King's College London have been awarded £191,000 to enhance the prediction of aortic coarctation by adapting their established biomarker from MRI to ultrasound. The goal is to improve the accuracy of CoA diagnosis before birth using routine 2D scans.
The 2020 facility revision criteria for rotational atherectomy did not increase adverse events among patients treated for coronary artery disease. The expansion of RA eligibility to low-volume, non-training hospitals improved patient care and reduced geographical disparities.
Research reveals altered brain networks in newborns with congenital heart disease, which may be linked to sensory perception, movement, and social behavior. After corrective surgery, these brain networks are improved, suggesting that cardiac surgery can improve brain health.
A team of researchers from the University of Oldenburg has discovered a unique genetic pattern, or 'fingerprint', associated with NOTCH1 gene variants that commonly cause congenital heart defects. This breakthrough enables more reliable diagnoses and targeted therapies for patients and their families.
A Mount Sinai-led study developed an AI tool that analyzes ECGs to identify patients at risk for harmful heart changes, potentially reducing the need for expensive and time-consuming cardiac MRI scans. The tool could make lifelong heart monitoring more accessible and efficient for people born with congenital heart disease.
Researchers at Adelaide University have uncovered a crucial new mechanism controlling heart development by regulating key growth signals. Neural crest cells fine-tune Wnt signalling to ensure proper heart formation, and disruptions lead to serious congenital heart defects.
The Mount Sinai Hospital has received an $8.5 million NIH grant renewal to continue groundbreaking research on long-term outcomes for children with congenital heart disease. The project will unite clinical leaders and registry data from all 25 congenital heart surgical centers across four states to study how differences in health care ...
Adults born with heart defects are at increased risk of cardiac complications as they age. The new guideline provides recommendations for monitoring, counseling, and treating Congenital Heart Disease (CHD), including mental health assessment and physical activity guidance. It also emphasizes the importance of access to ongoing speciali...
Researchers at Penn State are developing a small, durable ventricular assist device (VAD) specifically designed for young children with heart failure. The PSU Child VAD aims to provide long-term support while waiting for a heart transplant, improving quality of life and outcomes.
Researchers have identified a distinct type of frailty in younger people driven by cardiovascular and metabolic illnesses, leading to poor outcomes and premature death. The study calls for routine frailty assessments in all heart attack patients, regardless of age.
A study published in JAMA Network Open found that more prenatal visits are associated with a lower likelihood of delivery at a cardiac surgical center for babies with mild congenital heart defects. This suggests that families can receive the right level of care closer to home, reducing stress and cost.
A recent study analyzed data from 4,348 pediatric patients with congenital heart disease to identify key predictors of prolonged ICU stays. The research highlights the importance of patient-specific and post-operative management factors in reducing extended care.
Researchers have discovered a previously unknown group of cells that produce adrenaline, which may help the fetal heart adapt to stress. The study provides a detailed map of the developing human heart, revealing over 70 distinct cell types and their interactions.
Researchers at Gladstone Institutes discover a gene called HMGN1 that disrupts DNA packaging and regulation, leading to heart malformations in people with Down syndrome. Removing the extra copy of HMGN1 from mice with Down syndrome prevents heart defects, paving the way for potential treatments.
Researchers found a drug that blocks harmful immune proteins, preventing congenital heart block in newborns. A multicenter trial is planned to assess the effectiveness of the drug in preventing congenital heart block.
A case series of 19 patients has successfully undergone partial heart transplant, enabling valve growth and representing a novel approach to congenital heart disease treatment. Careful follow-up and monitoring are crucial for the continued expansion of this procedure.
The Society for Cardiovascular Angiography & Interventions (SCAI) has published a new position statement providing best-practice guidance for the treatment of patent ductus arteriosus (PDA) in premature infants using transcatheter occlusion. The guidance emphasizes patient selection, pre-procedural planning, and post-procedure follow-u...
A team of scientists has found that the ion channel PIEZO2 is crucial for coronary vessel formation and heart development. Without PIEZO2, coronary arteries may develop improperly, leading to oxygen supply issues in the heart muscle. This discovery could lead to earlier diagnosis and treatment of congenital heart defects.
Scientists have discovered a link between autism spectrum disorders and congenital heart disease, finding that tiny hair-like structures called cilia underlie the shared biology of both conditions. This study offers hope for early diagnosis and intervention, with potential benefits for children with autism.
Pediatric hearts fail due to acquired and genetic disorders or congenital heart disease, requiring mechanical circulatory support (MCS) devices. However, adult devices are often used off-label in pediatric patients, deterring innovation and limiting access to life-saving technology.
Researchers discovered that mothers who are anemic in early pregnancy have a 47% increased likelihood of giving birth to a child with congenital heart disease. This finding suggests that widespread iron supplementation could help prevent congenital heart disease in many newborns before it develops.
The Mount Sinai Fuster Heart Hospital cardiology faculty practice has received the 2024 Human Experience Pinnacle of Excellence Award from Press Ganey, a leading patient experience organization. The hospital ranks among the top 5% of healthcare providers in delivering patient experience over three years.
A study led by University of Bristol found that COVID-19 pandemic reduced elective surgery in children with CHD, but did not increase post-operative complications or death. The research suggests prioritizing urgent and emergency procedures may be appropriate during healthcare disruptions.
A national study in Australia aims to understand the genetic cause of rare diseases, improving diagnoses and treatment options for those affected. The study is recruiting Australians with a known or suspected rare genetic disease to gather information and connect them with future research opportunities.
Researchers identified 60 genes linked to congenital heart disease, with some also contributing to neurodevelopmental disorders like autism. The study provides new insight into the genetic architecture of CHD and has implications for prenatal screening and early risk assessment.
This special issue explores AI's applications across various subspecialties, including coronary interventions, structural heart disease, and cardiovascular imaging. It highlights the importance of responsible AI integration and addressing bias in decision support systems.
Researchers report a significant increase in congenital heart defects in states with restrictive abortion laws, exceeding pre-Dobbs trends. This trend is associated with higher healthcare utilization needs and potential non-financial strains on families.
Research from the Long Life Family Study found individuals from long-lived families have significantly better vascular health than the general population. The study identified key risk factors and four genomic regions linked to PAD risk, providing novel insight into underlying mechanisms.
A new study highlights the need for more diversity in genomics research, as a commonly found gene variant was mistakenly linked to heart disease in people from Oceanian communities. The researchers found that the variant is actually common among healthy individuals from these regions.
Researchers identified a single gene, CIROZ, responsible for pediatric heart defects and abnormal organ placement. The study found that mutations in this gene can lead to severe heart defects at birth, emphasizing the importance of preventive strategies and curative therapies.
Researchers explore ataciguat to manage aortic valve stenosis, showing potential to significantly slow disease progression. The drug may enable a once-in-a-lifetime procedure by delaying valve replacement surgery.
Researchers at The Mount Sinai Hospital have identified 10 novel gene pairs potentially linked to the development of CHD. Their study uses trio exome sequencing data to uncover previously hidden genetic risks, which could improve diagnostic precision and open new avenues for personalized treatment strategies.
A study of 252 patients who underwent the Ross procedure found that survival rates were 95.8% at 5 years, 94.3% at 10 years, and 90.3% at 20 years. The procedure offers excellent long-term survival rates with low risk of re-intervention, making it an alternative to mechanical valve replacement.
Researchers document five cases of parvovirus B19-induced myocarditis in preschoolers from northern Greece, highlighting the virus's unique impact on endothelial cells. The study emphasizes the importance of quick diagnosis and treatment to reduce mortality and morbidity in children.
The WHO's Technical Advisory Group on Genomics published an article outlining challenges and actions to promote the use of genomics in public health. The group aims to increase awareness and provide technical guidance to accelerate access to genetic technologies, enabling preventive measures and targeted treatment for various diseases.
A recent study published in JAMA Network Open found that 84% of adults with congenital heart disease reported good or better health-related quality of life, despite complex CHD. However, participants with complex CHD were less likely to meet physical activity guidelines and reported mood disorders.
A study involving 4,500 participants has provided valuable insights into the long-term quality of life of adults with congenital heart disease (CHD). Key findings include a high percentage of participants experiencing comorbidities, arrhythmias, and mood disorders, while quality of life is generally good or better for 84%.
Research reveals that Black infants with congenital heart disease are 40% more likely to die in the first year than white infants, despite overall death rates decreasing for both groups. The American Academy of Pediatrics study found a significant disparity in mortality rates between Black and white infants born with heart abnormalities.
A recent study uses CNV-seq and WES to detect congenital heart disease, identifying genes contributing to CHD and increasing diagnostic yield. The combination of these technologies boosts detection rates for CHDs, improving prenatal management.
Parents who struggle with alcohol use disorders can pass along symptoms of early aging to their children, affecting them well into adulthood. These accelerated aging effects include high cholesterol, heart problems, arthritis, and early onset dementia.
A new $13 million project launched by the American Heart Association and Additional Ventures aims to study the biological mechanisms of single ventricle heart disease. The five-year initiative will bring together teams of scientists to expand understanding of underlying biological mechanisms and science related to clinical complications.
A new study from Israel found that nearly 1 in 5 adults with congenital heart disease developed an abnormal heart rhythm during a five-year study. Those who developed arrhythmias had twice the risk of early death and increased hospitalization rates compared to those without irregular heart rhythms.
Researchers aim to address LVAD shortcomings, reducing blood damage and clotting risk through innovative designs and coatings. A novel flexible stented blood inlet and slippery hydrophilic coatings will be used to prevent flow stasis and clot formation.
A new American Heart Association scientific statement offers the latest knowledge on neurodevelopmental outcomes in people of all ages with congenital heart disease. The statement highlights that neurodevelopmental difficulties are common complications faced by individuals with congenital heart disease, affecting their ability to funct...
A team of researchers from Texas Heart Institute and Baylor College of Medicine have made a significant discovery about the underlying molecular cell states within transplanted pediatric hearts. They found that donor-derived tissue-resident macrophages are crucial for graft acceptance, but their loss leads to allograft failure.